Maria N Fairbank, PhD, MSc

Maria Fairbank, PhD, MSc, is a Senior Clinical Research Scientist at Syner-G BioPharma Group. Prior to joining Syner-G BioPharma Group, Maria was a Senior Program Manager/Medical Writer II at Technical Resources International Inc, in Bethesda, MD.

Dr. Fairbank has medical writing experience supporting the National Institute of Allergy and Infectious Diseases (the Division of Microbiology and Infectious Diseases) and the National Cancer Institute (NCI, Cancer Therapy Evaluation Program), most recently as the Senior Program Manager for the NCI Centralized Protocol Writing Support Program for trials conducted by the Experimental Therapeutics Clinical Trials Network. With over 6 years of experience as a medical/regulatory writer, her therapeutic areas of interest and experience include oncology (immunotherapy), psychiatric disorders, and neurology. Overall, her work encompasses a number of submission level and study level documents, including Protocols and Amendments (Phase I through IV), Clinical Study Reports (Phase I through III), Investigational Brochures, Investigational New Drug (IND) Applications (ie, Module 2 documents), Clinical Overview Addendums (Module 2.5), IND Annual Reports, Developmental Safety Update Reports, IND patient safety reports and narratives, Informed Consent Documents, and Central Institutional Review Board Applications. Additionally, Dr. Fairbank has over 10 years of experience in academia either as a basic research scientist or as an instructor/mentor. Maria has a strong background in oncology, pharmacology, toxicology, physiology, molecular biology, and biochemistry.

Dr. Fairbank earned a MSc in Pharmacology and Toxicology from the University of Western Ontario (London, Ontario) in 2006 and a PhD in Cell and Developmental Biology from the University of British Columbia (Vancouver, British Columbia) in 2012.